| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |